Developing exoneural treatments for cancer, immunological, and regenerative diseases


Life-changing medicines through transformational science



Cygnal Therapeutics is developing drugs to manipulate exoneural biology for the treatment of cancer, immunological diseases, and regenerative processes. Powered by a comprehensive, cutting-edge neurotechnology platform, we are discovering new dimensions of neural function.

Cygnal was founded by Flagship Pioneering in the VentureLabs innovation foundry, and is located in the heart of Cambridge, MA. We seek exceptional and visionary scientists to join our team.

join our team.jpg
Final Flagship Logo_Artboard 4.png